This week (December 4-5, 2012), I am honored to chair and present at the World Drug Repositioning Conference in Washington DC. This conference brings together several key industry groups to share insight into how they are discovering new uses for drugs in their pipelines. The second day of the conference, I will be presenting on technology developed out group to infer drug-targets from phenotypic screens, work funded by Pfizer and GSK.
As the conference progresses, I will be adding my take here to this post. So please check back in.